Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New clot buster comparable to t-PA in AMI

March 18, 1997

Pharmacodynamic effects of xemilofiban in cirrhotics

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

NM-702 enters phase II trials

March 14, 1997

Boehringer Mannheim reports new antiplatelet agents

March 13, 1997

Agrylin granted priority review in Canada

March 7, 1997

Thrombin inhibitors disclosed by Astra

March 6, 1997

FDA advisory committee decision regarding Integrilin

March 4, 1997

Fibrinogen antagonists disclosed by Terumo

March 3, 1997

Abciximab and acute profound thrombocytopenia

Feb. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...